Bulging eyes can often be improved significantly with the right treatment, but the approach depends entirely on what’s causing them and whether the condition is still active or has stabilized. The most common cause by far is thyroid eye disease (TED), which drives about 60% of cases through inflammation and swelling behind the eyes. Fixing the problem typically involves a combination of managing the underlying condition, reducing inflammation during the active phase, and sometimes surgery once things settle down.
Why Eyes Start to Bulge
In thyroid eye disease, the immune system mistakenly attacks tissues behind the eye. White blood cells trigger a cascade of inflammation that causes the muscles controlling eye movement and the fat surrounding the eye to swell and expand. As this tissue grows, it pushes the eyeball forward in its socket. The eyelids can also retract, making the eyes appear even more prominent.
TED has two distinct phases. The active phase involves ongoing inflammation, and this is when the condition is getting worse. It typically lasts one to three years. After that comes the stable (or “burned out”) phase, where inflammation has stopped but the physical changes remain. Knowing which phase you’re in determines whether doctors treat with medication, surgery, or both.
Doctors use a Clinical Activity Score to assess which phase you’re in. It tallies up signs of active inflammation: eye pain (especially with movement), eyelid swelling and redness, redness on the white of the eye, and measurable changes like increasing protrusion or worsening vision over one to three months. A higher score points to active disease that responds to anti-inflammatory treatment.
Treating Active Inflammation
When the disease is still active, the priority is stopping the inflammation before it causes permanent damage. Intravenous steroids are the standard first-line treatment, delivered in weekly infusions over roughly three months. The goal is to calm the immune response enough to halt tissue expansion and protect the optic nerve. For patients whose optic nerve is under immediate threat, doctors use higher doses over several consecutive days to bring inflammation down quickly.
A newer treatment has changed the landscape considerably. Teprotumumab is an infusion therapy that blocks a specific receptor on the cells behind the eye, directly shrinking the swollen muscle and fat tissue. In clinical trials, 83% of patients treated with teprotumumab saw their eyes recede by at least 2 millimeters within 24 weeks, compared to just 10% on placebo. The average reduction was about 2.8 millimeters. Imaging studies showed it reduced eye muscle volume by roughly 33% to 35% and orbital fat volume by 17% to 29%. For many patients, this is enough to make a visible, meaningful difference without surgery.
Surgical Options After Stabilization
Surgery is reserved for after the disease has been stable for at least six months. Operating during the active phase risks unpredictable results because the tissues are still changing. When the time is right, there’s a specific sequence surgeons follow: orbital decompression first, then eye muscle surgery if needed, and eyelid surgery last.
Orbital Decompression
This is the primary surgery for reducing eye bulging. The surgeon removes bone from one or more walls of the eye socket, creating extra space for the swollen tissue to expand into rather than pushing the eye forward. Depending on severity, this can involve the lateral (outer) wall, medial (inner) wall, floor, or a combination. Fat removal alone is sometimes sufficient for milder cases. An endoscopic approach through the nose has become increasingly popular for medial wall decompression, avoiding external incisions.
The amount of correction depends on how many walls are decompressed. More walls removed means more space created and greater reduction in protrusion. Your surgeon will customize the approach based on how far your eyes are protruding and whether the goal is protecting your vision, improving appearance, or both.
Eyelid Surgery
Even after decompression, many people still have eyelid retraction, where the upper lid sits too high and exposes white above the iris. This contributes significantly to the “staring” appearance and also leaves the cornea vulnerable to drying out. Surgeons correct this by loosening or repositioning the muscle that holds the lid open. In some cases, they place a spacer material (options include tissue from the patient’s own body, donor tissue, or cartilage from the ear) to lengthen the lid and allow it to close more naturally.
Like orbital decompression, eyelid retraction measurements need to be stable for at least six months before surgery. The correction is precise, often measured in fractions of a millimeter, so operating on a moving target leads to poor outcomes.
Lifestyle Changes That Make a Difference
Smoking is the single most impactful modifiable risk factor. Heavy smokers are eight times more likely to develop thyroid eye disease than nonsmokers, and smoking makes existing disease worse and harder to treat. If you smoke and have TED, quitting is the most important thing you can do alongside any medical treatment.
Keeping your thyroid levels well controlled also matters. Both overactive and underactive thyroid states can worsen eye disease, so working with your endocrinologist to maintain stable levels supports whatever eye treatment you’re receiving.
For people with mild thyroid eye disease, selenium supplementation has shown some benefit in slowing progression. A clinical trial found it helpful for mild cases, though evidence for more severe disease is limited. The recommended daily allowance is 55 micrograms, and some doctors recommend a higher supplemental dose for TED patients specifically. This is worth discussing with your care team, as selenium can be harmful at very high doses.
Managing Symptoms While You Wait
Whether you’re in the active phase waiting for treatment to work or in the stable phase planning surgery, day-to-day comfort matters. Sleeping with your head elevated can reduce fluid buildup behind the eyes overnight, which is when many people notice their eyes feel most swollen and pressured. Lubricating eye drops help protect the cornea from drying out, especially if your lids don’t close completely during sleep. Some people tape their eyelids shut at night or use moisture-chamber glasses during the day to prevent corneal damage.
Cool compresses can ease puffiness and discomfort during flare-ups. Wraparound sunglasses help with both light sensitivity and wind exposure, which aggravates dry eyes. These measures won’t reverse the bulging, but they protect your eyes and reduce discomfort during a process that often takes months to resolve.
What to Expect From Treatment Overall
Fixing bulging eyes is rarely a single-step process. The typical journey starts with getting the underlying thyroid condition diagnosed and controlled, then managing inflammation during the active phase, and finally addressing residual cosmetic and functional issues surgically. From start to finish, this can span two to three years or more.
The good news is that outcomes have improved dramatically. Teprotumumab has given many patients significant improvement without surgery, and modern decompression techniques are more precise and less invasive than they were a decade ago. Most people end up with eyes that look and function much closer to normal, though some degree of residual change is common. The key is getting evaluated by a specialist in thyroid eye disease or an oculoplastic surgeon early, so treatment can begin before the damage becomes harder to reverse.